Quantbot Technologies LP Buys 24,400 Shares of Teleflex Incorporated $TFX

Key Points

• Quantbot Technologies LP increased its stake in Teleflex Incorporated by 86.5%, owning 52,610 shares worth $7.27 million as of the latest SEC filing.
• Teleflex's recent quarterly earnings showed earnings per share (EPS) of $3.73, surpassing estimates and indicating a 4.2% revenue increase year-over-year.
• The company announced a quarterly dividend of $0.34 per share, reflecting a 1.1% dividend yield and a payout ratio of 32%.

Quantbot Technologies LP lifted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 86.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,610 shares of the medical technology company's stock after buying an additional 24,400 shares during the quarter. Quantbot Technologies LP owned about 0.12% of Teleflex worth $7,270,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Banque Cantonale Vaudoise acquired a new stake in shares of Teleflex in the first quarter worth $27,000. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after buying an additional 100 shares during the last quarter. Costello Asset Management INC acquired a new stake in shares of Teleflex in the first quarter worth $28,000. Brooklyn Investment Group raised its stake in Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock valued at $29,000 after purchasing an additional 150 shares during the last quarter. Finally, Whipplewood Advisors LLC raised its stake in Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock valued at $32,000 after purchasing an additional 231 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Performance

Teleflex stock traded up $4.6850 on Friday, hitting $129.2950. The company's stock had a trading volume of 444,429 shares, compared to its average volume of 791,507. The firm has a market cap of $5.71 billion, a P/E ratio of 30.42, a price-to-earnings-growth ratio of 1.75 and a beta of 1.08. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The company has a fifty day moving average price of $117.96 and a 200-day moving average price of $131.26. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.36 by $0.37. The firm had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business's revenue for the quarter was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex's dividend payout ratio is presently 32.00%.

Insiders Place Their Bets

In other news, Director Jaewon Ryu bought 1,500 shares of the stock in a transaction dated Tuesday, August 5th. The shares were acquired at an average price of $115.00 per share, with a total value of $172,500.00. Following the acquisition, the director owned 3,727 shares in the company, valued at $428,605. This trade represents a 67.36% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stuart A. Randle bought 1,000 shares of the stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average cost of $115.86 per share, for a total transaction of $115,860.00. Following the acquisition, the director owned 7,547 shares in the company, valued at $874,395.42. The trade was a 15.27% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 5,500 shares of company stock worth $633,590 in the last quarter. 1.40% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

TFX has been the subject of several research analyst reports. Mizuho upped their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Wells Fargo & Company cut their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Royal Bank Of Canada upped their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research note on Friday, August 1st. Truist Financial cut their target price on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Finally, Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. One equities research analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.